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ABSTRACT

Arsenic is found as a contaminant of drinking water, rice, and other crops.
Epidemiological studies have shown that embryonic exposure to arsenic can cause
changes in behavior and reductions in growth, but the mechanisms for these effects are
not well understood. So, we were interested in examining potential mechanisms by
which arsenic could be affecting growth. Additionally, while many studies have looked
at higher levels of arsenic exposure, we wanted to focus on environmentally-relevant
levels to see if these concentrations could have lasting consequences on growth, even
after the exposure had ended.
Killifish (Fundulus heteroclitus) were used as the model organism for this
investigation for two reasons. First, they produce a large number of eggs, which can
increase statistical power when observing affects over multiple time points. Second,
earlier studies have shown effects on developmental processes at arsenic levels similar to
human exposures. In rodent or zebrafish models, investigators typically need to use
arsenic concentrations that are 100X higher to see similar effects. Thus, killifish were
exposed to 0, 10, 50, and 200ppb arsenic (as sodium arsenite) as embryos, and after
hatching were reared in clean water until adulthood at 28 weeks. The study was designed
to represent a full embryonic/fetal arsenic exposure in utero, and then to examine whether
effects persisted, worsened, or resolved into early adulthood. We found that growth,
assessed by condition factor (weight/length3), was significantly reduced by 24% in the
200 ppb embryonic exposure groups at 8 weeks, with a dose dependent decrease in the 10
and 50 ppb groups. These trends persisted up to 28 weeks, although variability was much
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higher. As we had seen similar reductions in growth in a previous embryonic arsenic
exposure study that used higher arsenic concentrations, we therefore investigated three
potential mechanisms responsible for the growth reduction.
First, we analyzed feeding behavior, as it has been found to correlate to amount of
nutrient intake. Embryonic arsenic exposure did indeed reduce the percentage of fish
initially responding to food and increased the amount of time it took for the fish to start
their response, particularly at the 28 week time period. So, one possibility is that arsenic
reduces activity or alters olfaction, thus reducing their response to food. The second
mechanism examined was whether embryonic arsenic exposure altered the morphology
of the intestine, or altered several specific cell types needed for nutrient uptake. There
was a slight, but statistically significant reduction in intestinal villus height at 16 weeks,
this change did not persist. Intestinal enterocytes and Goblet cell number, as measured
by immunohistochemistry, did not change with arsenic concentration or time. However,
the number of PCNA-positive intestinal cells, indicating cell proliferation, was reduced in
a dose-response manner at all sampling time points. This may indicate that embryonic
arsenic exposure permanently altered the ability of intestinal stem cells to proliferate.
The third possibility we examined was whether embryonic arsenic exposure
altered the expression of skeletal and hepatic insulin like growth factor (IGF-1), its
receptor (IGFR-1) on skeletal muscle cells, and its associated binding proteins (IGFBP-1
& -5) in the muscle and liver. We hypothesized that changes in their levels might alter
growth and muscle body weight, since epidemiological studies have found an inverse
relationship between arsenic and IGF-1 in plasma levels, which correlate to reductions in
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birth weight. Reductions of hepatic IGF1 and IGFBP-1 are highly correlated with
condition factor reductions in the 8 week old fish. However, by 28 weeks, hepatic IGF-1
and IGFBP-1 still remain tightly correlated, but are actually increased in a statistically
significant, dose-response manner. This might be a compensatory response to potentially
making up for any growth deficits seen in earlier stages.
Overall, the results from this study show that embryonic-only arsenic exposure
can alter growth factor expression, such as hepatic IGF-1, which correlates with a
reduction in condition factor during an essential growth period such as the juvenile stage.
As the fish reach sexual maturity, it appears that by increasing levels of IGF-1 and
restoring a consistent intestinal environment, they are able to compensate for early
growth deficits after embryonic exposure to lower levels of arsenic.
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CHAPTER ONE
LITERATURE REVIEW

Purpose of the study
In this study, our main objective is to determine whether arsenic exposure (10, 50,
and 200ppb) during early life stages reduces growth and alters feeding behavior long
after the exposure has ended, using killifish (Fundulus heteroclitus) as a model organism.

Arsenic species and occurrence in the environment
Arsenic (As) is a naturally occurring element found all over the world that has
known toxic effects on animals1. The degree of toxicity can depend on the As species,
since studies have shown that inorganic iAs (arsenite AsIII & arsenate AsV) as well as
GSH-mediated methyl organic metabolites (methylarsonate and dimethlyarsinate)2 can be
toxic 3,4. Arsenite and arsenate are most commonly found in aqueous environments due to
the weathering of rocks with arsenic sulfides, mining activity, combustion of fossil fuels,
which then interconvert from AsIII & AsV in an aqueous environment depending on pH
and redox conditions3,5. Since arsenite predominates in reducing anaerobic environments,
it is the form commonly found in groundwater6. Other organic arsenic species include
arsenobetanine, arsenosugars, and arsenocholine. Exposures to them are typically
through the diet, as they are commonly found in fish, shellfish, and poultry growth feed
additives (Rocxarsone)4,7,8. These forms have been found to be generally nontoxic2. In
addition, arsenic can form mono-, di-, and trimethylated metabolites. The different
oxidation states and chemical structure of arsenic species can correlate to its
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cytotoxicity9. For example, one study found that some human cells (hepatocytes,
keratinocytes, and bronchial epithelial cells) are more sensitive to cytotoxic effects of
MMAIII10 compared to inorganic AsIII 11. Another study found that DNA damage in
human hepatocytes and urotheial cells is induced primarily induced by MMAIII and
DMAIII 12.

Geographic arsenic water exposure
Throughout history and in the present day, arsenic has been used for industrial
and agricultural purposes such as the manufacturing of car batteries, alloyed
semiconductor materials, and as a pesticide13, as well as being, used as an effective drug
for treatment of acute promyelocytic leukemia (APL) 9. However, the major source of
human exposure to arsenic is through drinking water. In the past 10 years, China alone
has experienced at least 4 major arsenic water contamination accidents through illmanaged industrial waste discharge in the following water sources: 620 µg/L in
Xinqiang River, 570 µg/L in Duliu Creek, 180 µg/L in Yangzonghai Lake and 530 µg/L
in Dashahe River3. While the U.S. EPA drinking water standard is 10ppb (10µg/L),
higher levels can be found in private wells, which are often unregulated. These higher
levels of arsenic raise concern for roughly 13 million U.S households14. It was estimated
that 42.7 % of aquifers in the southwestern part of the U.S had greater than 10µg/L15.
Other parts of the U.S also have elevated arsenic levels. For example, 8% of wells
measured in Pennsylvania had concentrations > 10 µg/L 16, New England found that 30%
of wells had > 10 µg/L 17, North Carolina found around 1,436 wells out of 63,000 with
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levels higher than 10µg/L (maximum was 806µg/L) 15 and well water in Arizona can be
up to 61µg/L18. Additionally, arsenic pollution of water has been reported in
epidemiological studies in other countries including Chile (up to 110 µg/L As) 19,
Bangladesh (0.1-864 µg/L As) 20, Taiwan (<0.1-347.43 µg/L As) 21, and Hungary (0-50<
µg/L As)22 to list a few.

Dietary arsenic exposure
Not only are people exposed through their water supply, but arsenic has been
found in dietary sources. According to the European Food Safety Authority, the main
competent to the dietary exposure to iAs comes from grain-based processed products
such as wheat bread and rolls in adults, while infant and toddler exposures were from
rice, milk, and dairy products23. The mean dietary exposure in infants and toddlers ranged
from 0.20-2.09 µg/kg body weight/day, while adults ranged from 0.09-0.64 µg/kg body
weight/day21. In fish and seafood, there are usually greater amount of arsenobetaine and
arsenocholine, both of which have a lower potential for toxicity to humans23. Arsenic is
easily taken up into major food sources such as rice, which has been shown to accumulate
inorganic arsenic at a 10-fold high rate than other grains 24. One study examining arsenic
concentrations in various types of rice found levels of 200 µg /kg in brown rice, 130 µg
/kg in white rice, and 70 µg /kg in other color rice 25,26. Another study conducted a
product test investigating arsenic content in 9 different rice-based infant snacks found
ranges from 36.5-568 ng/g total As27.

3

A report in the U.S looking at dietary consumption patterns found that in some
infant formulas, infants could be exposed on average to 9.4-14 µg/day iAs when
consuming formulas using brown rice syrup as a healthy alternative to sugar. This study
also found adults consuming rice could be exposed to an average to 11 µg/day iAs28.
Based on epidemiology studies, arsenic exposure between 0.3 and 8 µg/kg body
weight/day was estimated to result in a 1% increased risk of lung skin and bladder tumors
in humans23. A recent European study looking at the need for arsenic risk reduction
deduced that based on a daily consumption of 2L of water a day at 10 µg/L arsenic by a
person weighing 70 kg equals 0.3µg/kg body weight/day which is in the 1% benchmark
does range for carcinogenesis23. Additionally, the U.S. Agency for Toxic Substances and
Disease Registry’s (ATSDR) Minimal Risk Levels (MRLs) for acute oral consumption at
5µg/kg/day and chronic oral consumption at 0.3µg /kg/day arsenic as safe doses for
infants28. In order to reduce the risk of cancer later in life for infants’ minimizing and
regulating the amount of arsenic exposure through diet and water is essential.

Naturally-occurring and anthropogenically-introduced arsenic sources continue to
raise the need for further investigation not only for arsenic remediation efforts but also
the mechanisms behind its toxic effects on animals. Furthermore, since studies have
shown that arsenic exposure in animals can contribute to cancer, behavior and cognitive
dysfunction, as well as impaired growth and development, it is extremely important to
investigate arsenic’s effects at early life stages29. It is also essential to understand the
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metabolism of arsenic and what species could potentially increase harmful developmental
effects.

Arsenic biotransformation in animals
In animals, arsenic (iAsV and iAsIII) is absorbed from the intestine and is typically
metabolized through a specific biotransformation pathway usually occurring in the liver.
It can enter a cell via aquaporins and is later exported, in part, through membrane bound
efflux transporters (MRPs) 5. The metabolism of iAs happens through a series of
oxidative methylation and reduction reactions that promotes As excretion in urine5. For
example, inorganic arsenic AsIII goes through oxidative methylation along with
conjugation of GSH to convert it into monomethyl arsenic or MMAv. MMAv is reduced
to MMAIII which undergoes oxidative methylation to form dimethylated arsenic or DMAv
by an S-adenosylmethionine -dependent enzyme termed arsenic methyltransferase
(As3MT) 4,30,31. The reduction of pentavalent As to trivalent As is usually mediated by
an arsenate reductase enzyme with the addition of a methyl group5. Figure A. shows a
general arsenic biotransformation pathway.

Figure A. General arsenic biotransformation pathway. Modified from Casarett and
Doull’s Toxicology 8th edition.
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All forms of arsenic - Asv, AsIII, MMA, and DMA can be detected in urine, with
DMA being the most commonly detected species5,32. These methylation pathways have
been seen in aquatic animals such as fish with metabolism usually occurring in the gills
and liver, but they have a greater tendency to accumulate arsenobetanine and
arsenocholine which are thought to be less toxic forms5. While methylation of iAs is an
attempt at detoxification, it can also be a bioactivating pathway that leads to greater
toxicity as studies have found that the intermediate trivalent methylated arsenicals
(MMAIII and DMAIII) can be more effective inhibitors of enzymes, and cause more
cytotoxicity and genotoxicity than iAs5,33.

Growth and intestinal development in mammals
As previously mentioned, arsenic and its metabolites can impair growth and
development. In order to understand these effects, it is first important to understand
normal animal development. In mammals after sperm entry into the egg, the first
cleavage begins about a day later and the two nuclei produced by this cleavage are the
first to contain the entire genome. During cleavage events, the zygotic genome is
activated at different times depending on the species; human zygotic genes, genes
transcribed by the zygote’s DNA, are activated at the 8- cell stage, whereas mouse and
goat zygotic genes can be activated in late zygote stage and continue through 2-cell stage.
In order for zygotic genes to be activated, parental chromatin undergoes changes and
gamete-specific methyl groups on DNA are removed unless imprinted, and new DNA
methylation patterns are established. By the 8-cell stage, the genome of each cell is
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hypomethylated and appear to be pluripotent which sets the stage for cell differentiation
to occur34.

The blastocyst contains trophoectoderm cells which will give rise to
extraembryonic tissues like the chorion around day 10-12 in humans, and an inner cell
mass with pluripotent cells which will give rise to the embryo. The inner cell mass then
delaminates into the epiblast, which becomes the three germ cell layers during
gastrulation. Around day 12-15, the primitive streak is formed, which goes on to form
embryonic mesoderm (giving rise to muscles, skeleton, connective tissue, reproductive
organs, kidneys, and circulatory structures) and endoderm (gives rise to the
gastrointestinal tract, lining of respiratory tract, and organs like the liver and pancreas)
while the embryonic epiblast forms the embryonic ectoderm (gives rise to the nervous
system)34. After the completion of gastrulation, organogenesis begins around 5 weeks in
humans.

As previous studies in our lab have noticed a reduction in growth of killifish
exposed to arsenic as embryos, we wanted to determine if arsenic might have an effect on
intestinal development, potentially leading to a reduction in nutrient uptake and growth.
The endodermal function in the embryo is to construct the linings of the digestive tube,
which is signaled by the Sox17 transcription factor that is necessary for gut endoderm
morphogenesis35. The digestive tube constricts to form the esophagus followed by the
stomach, small intestine, and large intestine, and then puts out branches that become the
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thyroid, thymus, pancreas, and liver36. Gut tissue forms by reciprocal interactions
between endoderm and mesoderm. Signals playing a role in specification of the gut tube
are typically in gradients and Wnt is thought to be important in this process36. Wnt
signals, which are instructed by RA (retinoic acid) and FGF gradients from posterior
mesoderm, induce the posteriorizing transcription factors Cdx1, Cdx2 as well as
paracrine factor Indian hedgehog that play a role in intestine formation. At high
concentrations, Cdx1 and 2 induce the formation of the large intestine, and at low
concentrations, they induce the formation of the small intestine36. In the anterior region of
the gut tube, which forms thymus, pancreas, stomach, and liver, Wnt signaling is
blocked. In the stomach forming area, the gut tube mesenchyme lining expresses
transcription factor Barx1 which turns on Frzb-like Wnt-blocking proteins. In a study
observing intestinal development in mice showed that villi form around embryonic day
15 and the crypts, where stem cells reside, were set up shortly after birth due to the
expression of Hedgehog. Growth of the villus is promoted by BMP2 and 437. The
morphogenesis of villi and crypts occur by folding of the endodermal epithelium and
depends on the decreased expression of ephrin B1 in villi and increased ephrin B2 and 3
in the crypts where β-catenin plays a role in repression and up regulation of these
proteins, respectively37. Additional studies on mice have found that cells expressing adult
intestinal stem cell markers such as Lgr5, Ascl2, and Olfm4 appear around embryonic
day 15 and reside in the inter-villus region, suggesting that Wnt-dependent progenitors of
adult intestinal stem cells are established prior to birth38. In this study, they found that
Lgr5 progenies give rise to all differentiated intestinal epithelial cell types including;
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enterocytes, enteroendocrine, goblet, and Paneth cells38. The enterocytes are the most
abundant intestinal epithelial cells, making up to about 80% of all epithelia cells. They
function in increasing the absorptive surface, and have hydrolytic and absorptive
functions to take up and degrade nutrients39. In mice, the turnover rate for enterocytes is
estimated to be around 3 days. Goblet cells represent about 5% of the epithelial cells and
contain mucus that constitutes a barrier against the intestinal contents. Turnover for
goblet cells is around 3 days as well. Enteroendocrine cells make up a much smaller
percentage of the intestinal epithelial cells and they produce hormones that help in
regulating gastrointestinal motility. Paneth cells function mostly in antimicrobial defense
of the intestine, roughly 10 Paneth cells are present per crypt, and they and have a slower
turnover rate of about 20 days39.

The rapid cell division in crypts is dependent upon Wnt/β-catenin signaling37. The
stem cells divide rapidly into progenitor cells in the intestine then take on their fate based
on signals from genes such as Math1 (aka Atoh1)40, which promotes the fate of secretory
(goblet and endocrine) cells along with a decrease in Notch41. Whereas the Notch ligand
Delta turns on transcription factors such as Hes-1 to specify enterocyte fate41. Below is a
general diagram of these signals and the fate of the stem cell in Figure B.
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Figure B. Signals involved in the intestinal crypt based columnar cell (CBC) and
Lgr5 marked stem cell fate. Modified image from (Boaz et al., 2014)

As embryonic development is complete and the fetus is growing, in utero
signaling pathways such as insulin-like growth factor (IGF-1) is extremely important for
growth. In humans serum IGF-1 concentration from 15-37 weeks of gestational age there
is a positive correlation with IGF-1 concentration and fetal weight and bone length42.
Similarly, umbilical cord IGF-1 levels reflect fetal IGF-1 levels at birth and decreased
IGF-1 levels correlate with a decrease birth weight in humans. There has also been
evidence that IGF-1 is detectable in fetal tissue in the first trimester suggesting IGF-1
might play a role in early development42. Similar to mammals, IGF-1 signaling plays a
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role in juvenile fish development, providing evidence of its significance for normal
growth43. A general diagram of IGF-1 signaling pathway located in Figure C.

Growth and development in fish
My work uses killifish (Fundulus heteroclitus) as model organisms. Fish eggs are
telolecithal meaning the majority of the egg cell cytoplasm is occupied by yolk44.
Cleavage can only occur in a thin region of the yolk free cytoplasm called the blastodisc.
The first cell divisions after fertilization have a reproducible pattern of meridional and
equatorial cleavage. Fish embryos undergo mid-blastula transition, which is when zygotic
gene transcription begins around the 10th cell division. At this time three distinct cell
populations develop: the yolk syncytial layer (role in directing cell movements of
gastrulation), the enveloping layer which is a protective covering that allows the embryo
to develop in hypotonic solutions, and the deep cells which give rise to the embryo
proper44.
During gastrulation, all three layers undergo epiboly, the movement of epithelial
layers that spread to enclose the deeper layers of the embryo, and progress through it until
the entire yolk cell is covered by the blastoderm44. Once the blastoderm has covered
about half the yolk cell, a thickening occurs referred to as the germ ring which is made of
the epiblast (later to be the ectoderm) and the hypoblast (later to be the endoderm and
mesoderm). The endoderm expresses casanova (Sox 32) and spiel-ohne-grenzen (Oct 4)
genes controlled by nodal which will become intestine, liver, and pharynx. Mesoderm
expresses genes like notail (brachyury) and spadetail (Tbx6 and VegT) which will
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become heart, muscle, head, blood, and fins45. Ectoderm expresses BMPs and certain
Wnt proteins which will become epidermis, brain, nose,
eye, and spinal cord. Once organogenesis is complete and
the fish continues to grow to adulthood, signaling
pathways such as IGF play a role in growth by promoting
proliferation and differentiation of growing tissue, similar
to fetal growth in humans. As shown in Figure 2, IGF
binds to specific receptors on the cell surface of growing
tissue to mediate proliferation. It can also bind to IGF
binding proteins (IGFBPs) that have various functions,
Figure C. IGF-1 Signaling pathway to
promote cell proliferation.

depending on the tissue type and the health status of the
organism46. The binding proteins can aid in the control of

IGF distribution between extracellular environments and cell surface binding sites, and
may also regulate IGF bioactivity by modulating its interaction with the receptor46. For
example, like growth factor binding protein-1 (IGFBP-1) is found predominantly in the
liver and inhibits the bioavailability of IGF typically under stressful conditions47. In one
study in zebrafish, they found that under times of starvation, IGFBP-1 was significantly
increased47. In contrast, IGFBP-5 located primarily in the muscle is considered promyogenic and increases the bioavailability of IGF during myoblast differentiation playing
an important role in fish muscle growth48. Additionally, other factors related to the
gastrointestinal systems play a role in fish growth such as peptide transporters located on
enterocytes and part of the brush border membrane. They play a major role in animal
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growth through amino acid transport and availability. Peptide transporter 1 (PEPT1) is
primarily involved in the uptake of dietary protein degradation products and fish
growth49. In studies using PEPT1 knockout mice, body weight was reduced and
microvilli were shortened50.

Intestinal development and stem cell signals in fish
Intestinal development in fish is like that of mammals. While not much
investigation has been done on killifish intestinal development, its development in
zebrafish has been thoroughly investigated. One study found that the intestinal tract has
undergone extensive remodeling around the fourth day of development, along with
compartmentalization into three main segments: the intestinal bulb, mid-intestine, and
posterior intestine, which will be composed of cells that will perform specialized
functions51. These specialized cells consist of enteroendocrine cells, which are hormone
secreting cells observed 52-76 hours post fertilization, goblet cells, which secrete
mucous, and enterocytes, which are absorptive cells, both observed 76-126 hours post
fertilization. After 5 days of development, epithelial folding is more extensive in the
intestinal bulb while mid- and posterior intestine remain unfolded and the presence of
goblet cells and enterocytes is restricted to the mid-intestine. The folding processes
proceeds rostrocaudally, as it does in mammals, with folding in the mid-intestine
appearing around 8 days and folding in the posterior intestine appearing around 12
days51. The morphological characteristics of the intestinal bulb represent tall fold (plicae)
or villus like extensions, which become progressively shorter through the mid to posterior
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intestine. Although zebrafish and other minnows lack crypts where stem cells reside,
they do have proliferative compartments at the base of the villus-like folds 51.

Differentiation of intestine stem cells in zebrafish is dependent on the same
pathways and signals seen in mammals. Delta, the Notch ligand, accumulates in
secretory cells of zebrafish gut and activates the Notch cascade in neighboring cells,
which turns on transcription factors (Hes-1) specifying enterocyte fate, in part due to the
repression of Ascl1a. Ascl1a is a gene that plays a role in specification of goblet and
enteroendocrine cells52. Like mammals, epithelial cells in zebrafish migrate from the
base of the intestinal folds to the tip of the fold within 5-7 days in the anterior intestine
and 7-10 days in the mid intestine. Mechanisms driving differentiation of epithelial cells
towards the secretory lineage (goblet cells or enteroendocrine) seems to be highly
conserved in vertebrates and dependent on Delta-Notch signaling41, 53, 54. Interestingly,
previous studies in our lab looking at arsenic’s effects on neuronal cell differentiation
found that arsenic exposure decreased Ascl1 expression by 2.5-, 7-, and 4-fold on days 5,
7 and 9 of stem cell differentiation. An increase in Ascl1 expression has been shown to
promote neuronal differentiation, so decreased expression could be a mechanism by
which arsenic inhibits stem cell differentiation55. As stated above, Ascl1a also plays role
in intestinal stem cell differentiation, which suggests that it may also be reduced in the
intestine of embryonically exposed killifish, and therefore reduce intestinal cell
development. Therefore, arsenic exposure during development is a major concern.
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Arsenic’s effect on growth and development
It is known that arsenic can easily cross the placental barrier 29. A study in
Bangladesh investigated levels of arsenic in maternal and cord blood of pregnant women
who were drinking water with of 90.5μg As/L which is much higher than the 10μg/L
standard set by the WHO56. They found that arsenic levels in the maternal blood
(11.7μg/L) and cord blood (15.7μg/L total arsenic) were similar, indicating that the fetus
was also readily exposed to arsenic levels that could interfere with growth and
development56. A mass poisoning event occurred in 1955 in Japan where bottle-fed
infants were exposed to about 500μg arsenic/kg body weight through their formula
(Morinaga milk powder) and led to more than 100 infant deaths. Infants less than 12
months of age had symptoms of anorexia, skin pigmentation, diarrhea, vomiting, fever,
and abdominal distention which was first misdiagnosed as bronchitis or pneumonia until
the link between patient’s dried milk brand and arsenic content was made57,58. This event
raised a need to investigate arsenic’s long term effects following an early life-stage
exposure. Another study followed the arsenic exposed infants 50 years later, and found
among 50 individuals their average height was 6.5 cm below the control group indicating
there might be potential for abnormalities in proper skeletal growth due to early life
arsenic exposure59. Another study looked at neurological issues in these patients and
found that the group exposed as infants to arsenic exhibited neuropsychological deficits
such that they showed an average performance of at least 1.2 standard deviations below
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the average for the control unexposed group in memory tests57, had drastically reduced
IQs, and increases in central nervous disorders like epilepsy and mental retardation58
Other studies have found reductions in birth weight and gain following in infants exposed
in utero to arsenic. For example, a study in Bangladesh examining low level arsenic
exposure (<100ppb) during pregnancy found a significant decrease in birth weight, with
each 1µg/L increase in urinary being associated with a 1.68 g reduction in birth weight60.
A European study looking at prenatal exposure to chemical mixtures found that arsenic
was the only chemical in the mixture to have a significant inverse correlation to babies’
birth weight, declining 90g as arsenic increased in cord blood samples61. Additionally, a
study in Bangladesh found that with increasing arsenic levels, IGF-1 plasma levels were
significantly decreased and correlated with reduced birth weight62. Long term, in utero
arsenic exposure has been associated with reductions in weight gain. For example, a
study in Bangladesh followed pregnant woman exposed to arsenic and cadmium. They
found that the children at 5 years of age had a reduction in weight gain and height with
41% of the children being underweight and 33% were stunted, and that these effects were
most apparent in girls63.

Similar findings have been seen in animal models. In a study looking at the
effects of dietary arsenic exposure in juvenile rainbow trout found that there was a
significant 15 and 34% decrease in weight gain in fish that fed on oligochaetes exposed
to 4.5mg/L and 8.2mg/L As respectively. The uptake of arsenic into these oligochaetes
ranged from 35- 58µg As/g dry weight 64. A study looking at mice found that drinking
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water arsenic exposure (10 ppb & 42.5 ppm) from gestational day 10 until birth was
correlated with significantly greater body weight gain, fat content, and glucose
intolerance through young adulthood65. Moreover, a study looking at rats exposed to 100
ppb arsenic during development plus a western style diet found an increase in body
weight beginning at week 5 until the end of the study at week 15 66. Not only are studies
finding a reduction in weight at birth but they are also finding an increase in body weight
later in life which some studies think this could be a result of diet66. As a handful of
studies have shown that arsenic was correlated with a reduction in weight gain, it is
crucial to begin to discover some of the underlying mechanisms involved. Arsenic has
been analyzed in studies of weight gain and IGF-1 which could be a potential pathway of
concern as IGF-1 is a major factor in growth and cell proliferation but it would also be
interesting to investigate arsenics effects on the intestine as it is the primary organ of
nutrient uptake which is essential for proper growth.

Arsenic exposure and behavior
Arsenic has also been shown to influence animal behavior, and alterations in
feeding and the ability to detect and recall food in the environment could lead to changes
in nutritional uptake, and decrease growth and survival. A study discovered that
weanling rats exposed to arsenic displayed an impairment in spatial memory after putting
them through hidden platform acquisition tests and visible platform trials67. In this study,
both adult and infant rats exposed to arsenic were tested using a variety of operant
condition tests. The study found learning deficits and time required to learn a new task
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was increased in rats exposed as infants compared the unexposed controls 67. Another
study looking at photo motor response as a behavioral assay in zebrafish embryos
exposed to 900-1,000µM As found that the arsenic exposed embryos exhibited
hypoactivity68. Additionally, a study reported that As at 0.75 mM impaired long term
memory in avoidance training behavioral tasks, providing more evidence that arsenic
could be affecting normal brain development and function as a neurotoxicant69.

For fish, olfaction is crucial to behaviors such as finding food, selecting mates,
migratory routes, and evaluating the risk of predation. An olfaction study in rainbow trout
showed that metals, such as cadmium and copper, reduced the ability of rainbow trout
olfactory epithelium to L-alanine and taurocholic acid70. L-alanine mimic’s food
detection and taurocholic acid should elicit a social response via olfaction70. This study
demonstrates that exposure to metals can cause impairments of the olfactory response in
fish, which could result in a variety of behavioral deficits such as food detection.
We hypothesize that changes in feeding behavior in fish exposed to arsenic could be
another potential mechanism for weight gain reductions.

In humans, behavior related studies have focused more on arsenics effects on
memory, IQ, learning, anxiety and depression. A meta-analysis study focused on
arsenic’s effects on intelligence in children (5-15 years old) found that increases in
urinary arsenic reduced IQ71, 72. Additionally, a study in India looking at children (5-15
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yrs) with an average lifetime arsenic exposure of 147µg/L found a 12-20% decrease in
vocabulary, object assembly, and picture completion test score73.

Hypothesis and rationale
I hypothesize that arsenic exposure during embryogenesis results in a reduction in
weight gain in our model species, killifish. The potential mechanisms that I will be
examining are: 1) changes in feeding behavior 2) alterations in IGF signaling pathway
expression, and 3) changes in intestinal morphology possibly interfering with nutrient
uptake. I hope the results from these data could help elucidate if the arsenic standard
drinking water limit (10 ppb) is protective of proper embryo growth and development,
and if there are any long-term consequences to exposures of environmentally relevant
arsenic levels (50 and 200ppb).

19

References

1. Jomova K, Jenisova Z, Feszterova M, et al. Arsenic: Toxicity, oxidative stress and human
disease. J Appl Toxicol. 2011; 31(2):95-107.

2. Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease.
Toxicology. 2011; 283:65.

3. Zheng L, Liu Z, Yan Z, et al. Deriving water quality criteria for trivalent and pentavalent
arsenic. Sci Total Environ. 2017; 587–588:68-74.

4. Sattar A, Xie S, Hafeez MA, et al. Metabolism and toxicity of arsenicals in mammals. Environ
Toxicol Pharmacol. 2016; 48:214.

5. Ventura-Lima J, Bogo MR, Monserrat JM. Arsenic toxicity in mammals and aquatic animals:
A comparative biochemical approach. Ecotoxicol Environ Saf. 2011; 74(3):211.

6. Mohan D, Pittman C Jr. Arsenic removal from water/wastewater using adsorbents-A critical
review. J Hazard Mater. 2007.

7. Nachman KE, Baron PA, Raber G, et al. Roxarsone, inorganic arsenic, and other arsenic
species in chicken: A U.S.-based market basket sample. Environ Health Perspect. 2013;
121(7):818-824.

8. Chung JY, Yu SD, Hong YS. Environmental source of arsenic exposure. J Prev Med Public
Health. 2014; 47(5):253-257.

20

9. Khairul I, Wang QQ, Jiang YH, et al. Metabolism, toxicity and anticancer activities of arsenic
compounds. Oncotarget. 2017; 8(14):23905-23926.

10. Petrick JS, Ayala-Fierro F, Cullen WR, et al. Monomethylarsonous acid (MMA(III)) is more
toxic than arsenite in chang human hepatocytes. Toxicol Appl Pharmacol. 2000; 163(2):203-207.

11. Styblo M, Del Razo LM, Vega L, et al. Comparative toxicity of trivalent and pentavalent
inorganic and methylated arsenicals in rat and human cells. Arch Toxicol. 2000; 74(6):289-299.

12. Dopp E, Recklinghausen Uv, Diaz-Bone R, et al. Cellular uptake, subcellular distribution and
toxicity of arsenic compounds in methylating and non-methylating cells. Environ Res. 2010;
110(5):435.

13. Hyun Soo Kim*, Yeo Jin Kim*, Young Rok Seo. An overview of carcinogenic heavy metal:
Molecular toxicity M echanism and prevention. Journal of Cancer Prevention. 2015; 20(4):232240.

14. Flanagan SV, Spayd SE, Procopio NA, et al. Arsenic in private well water part of 3:
Socioeconomic vulnerability to exposure in maine and new jersey. Sci Total Environ. 2016.

15. Naujokas MF, Anderson B, Ahsan H, et al. The broad scope of health effects from chronic
arsenic exposure: Update on a worldwide public health problem. Environ Health Perspect. 2013;
121(3):295-302.

16. Frederick L, VanDerslice J, Taddie M, et al. Contrasting regional and national mechanisms
for predicting elevated arsenic in private wells across the united states using classification and
regression trees. Water Res. 2016; 91:295.

21

17. Ayotte JD, Montgomery DL, Flanagan SM, et al. Arsenic in groundwater in eastern new
england: occurrence, controls, and human health implications. Environmental Science \&
Technology. 2003; 37(10):2075-2083.

18. Tsuji JS, Perez V, Garry MR, et al. Association of low-level arsenic exposure in drinking
water with cardiovascular disease: A systematic review and risk assessment. Toxicology. 2014;
323:78.

19. Liaw J, Marshall G, Yuan Y, et al. Increased childhood liver cancer mortality and arsenic in
drinking water in northern chile. Cancer Epidemiol Biomarkers Prev. 2008; 17(8):1982-1987.

20. Chen Y, Graziano JH, Parvez F, et al. Arsenic exposure from drinking water and mortality
from cardiovascular disease in bangladesh: Prospective cohort study. BMJ. 2011;
342:10.1136/bmj.d2431.

21. Liang C, Wang S, Kao Y, et al. Health risk assessment of groundwater arsenic pollution in
southern taiwan. Environ Geochem Health. 2016; 38(6):1271-1281.

22. Rudnai T, Sandor J, Kadar M, et al. Arsenic in drinking water and congenital heart anomalies
in hungary. Int J Hyg Environ Health. 2014; 217(8):813-818.

23. Gundert-Remy U, Damm G, Foth H, et al. High exposure to inorganic arsenic by food: The
need for risk reduction. Arch Toxicol. 2015; 89(12):2219-2227.

24. Azizur Rahman M, Hasegawa H, Mahfuzur Rahman M, et al. Arsenic accumulation in rice
(oryza sativa L.): Human exposure through food chain. Ecotoxicol Environ Saf. 2008; 69(2):317324.

22

25. Zavala YJ, Duxbury JM. Arsenic in rice: I. estimating normal levels of total arsenic in rice
grain. Environ Sci Technol. 2008; 42(10):3856-3860.

26. Diaz OP, Arcos R, Tapia Y, et al. Estimation of arsenic intake from drinking water and food
(raw and cooked) in a rural village of northern chile. Urine as a biomarker of recent exposure. Int
J Environ Res Public Health. 2015; 12(5):5614-5633.

27. Karagas MR, Punshon T, Sayarath V, et al. Association of rice and rice-product consumption
with arsenic exposure early in life. JAMA Pediatr. 2016; 170(6):609-616.

28. Wilson D. Arsenic consumption in the United States. Journal of Environmental Health. 2015;
78:3.

29. Vahter M. Effects of arsenic on maternal and fetal health. Annu Rev Nutr. 2009; 29:381-399.

30. Watanabe T, Hirano S. Metabolism of arsenic and its toxicological relevance. Arch Toxicol.
2013; 87(6):969-979.

31. Peters BA, Hall MN, Liu X, et al. Renal function is associated with indicators of arsenic
methylation capacity in bangladeshi adults. Environ Res. 2015; 143(0 0):123-130.

32. Middleton DR, Watts MJ, Hamilton EM, et al. Urinary arsenic profiles reveal exposures to
inorganic arsenic from private drinking water supplies in cornwall, UK. Sci Rep. 2016; 6:25656.

33. Yamanaka K, Kato K, Mizoi M, et al. The role of active arsenic species produced by
metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis. Toxicol Appl
Pharmacol. 2004; 198(3):385.

23

34. Gilbert SF. Early mammalian development. In: Azelie Aquadro, Carol Wigg, Elizabeth C.
Pierson, eds. Developmental biology. Tenth ed. Sunderland, Maryland USA: Sinauer Associates,
Inc.; 2014:299-315.

35. Viotti M, Nowotschin S, Hadjantonakis A. SOX17 links gut endoderm morphogenesis and
germ layer segregation. Nat Cell Biol. 2014; 16(12):1146-1156.

36. Gilbert SF. Endoderm. In: Azelie Aquadro, Carol Wigg, Elizabeth C. Pierson, eds.
Developmental biology. Tenth ed. Sunderland, MA USA: Sinauer Associates, Inc.; 2014:476-487.

37. Slack JMW. Stem cells. In: Essential developmental biology. Third ed. West Sussex, UK:
Wiley-Blackwell; 2013:343-347.

38. Nigmatullina L, Norkin M, Dzama MM, et al. Id2 controls specification of Lgr5+ intestinal
stem cell progenitors during gut development. EMBO J. 2017; 36(7):869-885.

39. De Santa Barbara P, Van Den Brink GR, Roberts DJ. Development and differentiation of the
intestinal epithelium. Cell Mol Life Sci. 2003; 60(7):1322-1332.

40. Merker SR, Weitz J, Stange DE. Gastrointestinal organoids: How they gut it out. Dev Biol.
2016; 420(2):239.

41. Takashima S, Gold D, Hartenstein V. Stem cells and lineages of the intestine: A
developmental and evolutionary perspective. Dev Genes Evol. 2013; 223(0):10.

42. Hellström A, Ley D, Hansen-Pupp I, et al. Insulin-like growth factor 1 has multisystem
effects on foetal and preterm infant development. Acta Paediatr. 2016; 105(6):576-586.

24

43. Reilly. Prepubertal expsosure to arsenic(III) suppresses circulating insuling-like growth
factor-1 (IGF-1) delaying sexual maturation in female rats. 2014.

44. Gilbert SF. Early zebrafish development. In: Azelie Aquadro, Carol Wigg, Elizabeth C.
Pierson, eds. Developmental biology. Tenth ed. Sunderland, MA USA: Sinauer Associates, Inc.;
2014:271-282.

45. Slack JMW. The zebrafish. In: Essential developmental biology. Third ed. West Sussex, UK:
Wiley- Blackwell; 2013:107-119.

46. Rechler MM, Clemmons DR. Regulatory actions of insulin-like growth factor-binding
proteins. Trends Endocrinol Metab. 1998; 9(5):176-183.

47. Maures TJ, Duan C. Structure, developmental expression, and physiological regulation of
zebrafish IGF binding protein-1. Endocrinology. 2002; 143(7):2722-2731.

48. Azizi S, Nematollahi MA, Mojazi Amiri B, et al. IGF-I and IGF-II effects on local IGF
system and signaling pathways in gilthead sea bream (sparus aurata) cultured myocytes. Gen
Comp Endocrinol. 2016; 232:7-16.

49. Verri T, Terova G, Dabrowski K, et al. Peptide transport and animal growth: The fish
paradigm. Biol Lett. 2011; 7(4):597-600.

50. Zhang Y, Viennois E, Zhang M, et al. PepT1 expression helps maintain intestinal homeostasis
by mediating the differential expression of miRNAs along the crypt-villus axis. Sci Rep. 2016;
6:10.

25

51. Ng ANY, Jong-Curtain TAd, Mawdsley DJ, et al. Formation of the digestive system in
zebrafish: III. Intestinal epithelium morphogenesis. Dev Biol. 2005; 286(1):114.

52. Roach G, Heath Wallace R, Cameron A, et al. Loss of ascl1a prevents secretory cell
differentiation within the zebrafish intestinal epithelium resulting in a loss of distal intestinal
motility. Dev Biol. 2013; 376(2):171-186.

53. Wallace KN, Akhter S, Smith EM, Lorent K, Pack M. Intestinal growth and differentiation in
zebrafish. Mech Dev. 2005; 122(2):157-173.

54. Brugman S. The zebrafish as a model to study intestinal inflammation. Dev Comp Immunol.
2016; 64:82-92.

55. Liu JT, Bain LJ. Arsenic inhibits hedgehog signaling during P19 cell differentiation. Toxicol
Appl Pharmacol. 2014; 281(3):243-253.

56. Hall M, Gamble M, Slavkovich V, et al. Determinants of arsenic metabolism: Blood arsenic
metabolites, plasma folate, cobalamin, and homocysteine concentrations in Maternal Newborn
pairs. Environ Health Perspect. 2007; 115(10):1503-1509.

57. Yorifuji T, Kato T, Ohta H, et al. Neurological and neuropsychological functions in adults
with a history of developmental arsenic poisoning from contaminated milk powder. Neurotoxicol
Teratol. 2016; 53:75.

58. Dakeishi M, Murata K, Grandjean P. Long-term consequences of arsenic poisoning during
infancy due to contaminated milk powder. Environ Health. 2006; 5:31-069X-5-31.

26

59. Yorifuji T, Matsuoka K, Grandjean P. Height and blood chemistry in adults with a history of
developmental arsenic poisoning from contaminated milk powder. Environ Res. 2017; 155:86-91.

60. Rahman A, Vahter M, Smith AH, et al. Arsenic exposure during pregnancy and size at birth:
A prospective cohort study in bangladesh. Am J Epidemiol. 2009; 169(3):304-312.

61. Govarts E, Remy S, Bruckers L, et al. Combined effects of prenatal exposures to
environmental chemicals on birth weight. Int J Environ Res Public Health. 2016;13(5):495.

62. Ahmed S, Rekha RS, Ahsan KB, et al. Arsenic exposure affects plasma insulin-like growth
factor 1 (IGF-1) in children in rural bangladesh. PLoS One. 2013; 8(11).

63. Gardner RM, Kippler M, Tofail F, et al. Environmental exposure to metals and children's
growth to age 5 years: A prospective cohort study. Am J Epidemiol. 2013; 177(12):1356-1367.

64. Erickson RJ, Mount DR, Highland TL, et al. The relative importance of waterborne and
dietborne arsenic exposure on survival and growth of juvenile rainbow trout. Aquatic Toxicology.
2011.

65. Rodriguez KF, Ungewitter EK, Crespo-Mejias Y, et al. Effects of in utero exposure to arsenic
during the second half of gestation on reproductive end points and metabolic parameters in
female CD-1 mice. Environ Health Perspect. 2016; 124(3):336-343.

66. Ditzel EJ, Nguyen T, Parker P, et al. Effects of arsenite exposure during fetal development on
energy metabolism and susceptibility to diet-induced fatty liver disease in male mice. Environ
Health Perspect. 2016; 124(2):201-209.

27

67. Tolins M, Ruchirawat M, Landrigan P. The developmental neurotoxicity of arsenic: Cognitive
and behavioral consequences of early life exposure. Ann Glob Health. 2014; 80(4):303-314.

68. Olivares CI, Field JA, Simonich M, et al. Arsenic (III, V), indium (III), and gallium (III)
toxicity to zebrafish embryos using a high-throughput multi-endpoint in vivo developmental and
behavioral assay. Chemosphere. 2016; 148: 361-368.

69. de Castro MR, Lima JV, de Freitas DP, et al. Behavioral and neurotoxic effects of arsenic
exposure in zebrafish (danio rerio, teleostei: Cyprinidae). Comp Biochem Physiol C Toxicol
Pharmacol. 2009; 150(3):337-342.

70. Dew WA, Veldhoen N, Carew AC, et al. Cadmium-induced olfactory dysfunction in rainbow
trout: Effects of binary and quaternary metal mixtures. Aquatic Toxicology. 2016; 172:86.

71. RodrÃguez-Barranco M, LacasaÃ M, Aguilar-GarduÃ C, et al. Association of arsenic,
cadmium and manganese exposure with neurodevelopment and behavioral disorders in children:
A systematic review and meta-analysis. Sci Total Environ. 2013; 455:562.

72. Rocha-Amador, Diana AND Navarro, Maria Elena AND Carrizales, et al. Decreased
intelligence in children and exposure to fluoride and arsenic in drinking water. 2007.

73. von Ehrenstein OS, Poddar S, Yuan Y, et al. Children's intellectual function in
relation to arsenic exposure. Epidemiology. 2007; 18(1):44-51.

28

CHAPTER TWO

EMBRYONIC ARSENIC EXPOSURE REDUCES GROWTH, ALTERS
FEEDING BEHAVIOR, INTESTINAL STRUCTURE, AND IGF SIGNALING
PATHWAYS
Kaleigh C. Sims, Katie L. Schwindinger, Dana B. Szymkowicz, William C. Bridges, Lisa
J. Bain
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Abstract
Arsenic is found as a contaminant of drinking water, rice, and other crops.
Epidemiological studies have shown that embryonic exposure to arsenic can cause
changes in behavior and reductions in growth, but the mechanisms for these effects are
not well understood. Thus, killifish were exposed to 0, 10, 50, and 200ppb AsIII as
embryos, and after hatching, were reared in clean water for up to 28 weeks. Growth,
assessed by condition factor (weight/length3), was significantly reduced in the 200 ppb
groups at 8 weeks by 24% with a dose dependent increase in 10 and 50 ppb. Significant
behavioral changes were also noticed at 16 and 28 weeks, including reduced response to
food. Additionally, there was a reduction in intestinal villus area and absorptive
intestinal surface area at 16 weeks. A decrease in liver IGF1 and IGFBP-1 transcript
levels were observed, particularly a decrease at 8 weeks when there was a reduction in
condition factor as well and an increase in muscle IGF1 and IGFBP-5. By 16 and 28
weeks, there is a shift in that IGF-1 liver and IGFBP-1 increase with arsenic exposure,
and are highly correlated to one another. We hypothesize that embryonic exposure to
arsenic impairs fish’s ability to maximize nutrient intake due to a decreased feeding
response and reduced numbers of intestinal enterocytes, ultimately causing compensatory
changes in key proteins of the IGF signaling pathway.
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1. Introduction
Arsenic (As) is a naturally occurring element found in water, sediments, and soils,
with the main route of exposure being drinking water. The most commonly found arsenic
species in aqueous environments are the inorganic forms, arsenite (AsIII) and arsenate
(AsV) with arsenite being the predominate species in groundwater1-3. Currently, the
World Health Organization (WHO) has set the standard for arsenic in drinking water at
10 ppb, although higher levels of arsenic are found all over the world in countries like
China, Bangladesh, Hungary, Chile, and Japan2,4-8. Even in the U.S., arsenic levels above
10ppb can be found in unregulated wells, exposing roughly 13 million households to high
arsenic concentrations in their drinking water9. The 10 ppb standard was set to help
protect people from chronic exposures that can cause cancer and cardiovascular diseases,
as well as potential developmental problems10,11. Not only is water a concern, but arsenic
has been found in dietary sources such as wheat bread, rice, milk and dairy products12.
Arsenic levels in rice, a staple crop for many people, pose a particular problem, as a study
found levels of 200 µg/kg in brown rice, 130 µg/kg in white rice, and 70 µg/kg in other
color rice13, 14. Another study investigated arsenic content in 9 different rice-based infant
snacks and found ranges from 36.5-568 ng/g total as15. These high levels of arsenic
content in rice and other snacks is alarming considering families that rely on rice a staple
crop can consume 0.4 kg of rice per day per person and dietary arsenic exposure between
0.3 and 8 µg/kg body weight/day was estimated to result in a 1% increased risk of lung
skin and bladder tumors in humans12.
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Studies have often focused on arsenic as a carcinogen, but less is known about
embryonic arsenic exposure and its effects on development and growth. It is known that
arsenic can cross the placental barrier exposing a developing fetus to this toxicant16, as
studies have found levels of arsenic in maternal (11.7μg/L) and fetal (15.7μg/L total
arsenic) blood to be similar17. A Bangladesh study found that exposure to arsenic (<100
ppb) during pregnancy was associated with a significant decrease in birth weight with
each 1µg/L increase in urinary As concentration being associated with a 1.68 g reduction
in birth weight18. A European study looking at prenatal exposure to chemical mixtures
found that arsenic was the only chemical in the mixture to have a significant inverse
correlation to babies’ birth weight, declining 90g as arsenic increased in cord blood
samples19. Additionally, a study in Bangladesh found that with increasing arsenic levels,
IGF-1 plasma levels were significantly decreased and correlated with reduced birth
weight20. In an animal model, mice exposed to 10 ppb As in utero and postnatally
weighed 18-23% less than the controls up to 42 days of age in female mice21.
In addition to changes in weight, other studies have found correlations between
arsenic exposure and behavioral changes, particularly in children. In Bangladesh, a study
looking at two cohorts of children at age 6 and age 10 found reduced intellectual function
and performance, and reduced processing speed with arsenic exposures between 550 μg/L during development22. Even studies on adults in India found that 19% of
patients aged 18-65 years old who were exposed to 25-900 μg/L arsenic exhibited
depression and/or anxiety-like behavior23. Animal models have also supported the trend
in behavioral alterations. A study found that both adult and juvenile rats exposed to
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arsenic had increased learning deficits and time required to learn a new task compared the
unexposed controls24. Additionally, a study looking at photomotor response as a
behavioral assay in zebrafish embryos exposed to 900-1,000µM As found that the
arsenic-exposed embryos exhibited hypoactivity25. Changes in behavior could potentially
reduce feeding activity, and therefore reduce growth.
While arsenic’s effects on growth and behavior have been investigated, very little
is known about its effects on the intestine, a key organ involved in the uptake of arsenic
from drinking water and food. One study using the HT-29 human intestinal epithelial cell
line did find that arsenic increased superoxide levels, causing dysregulation of barrier
functions in epithelial cells26. Additionally other metals, such as copper, induce oxidative
stress in fish intestinal enterocytes after in vivo and in vitro exposures27.
Intestinal development is similar in mammals and fish, although most fish lack
true crypts and instead have proliferative compartments at the base of the villus28. The
morphogenesis of villi and crypts occur by folding of the endodermal epithelium, and
stem cell markers such as Lgr5 and Ascl1 start to appear in the intervillus region29. The
Wnt/β-catenin and Notch signaling pathways are important in the differentiation of the
intestinal stem cells 29, 30. Like mammals, epithelial cells in zebrafish migrate from the
base to the tip of the intestinal fold within 5-7 days. Mechanisms driving intestinal cell
differentiation appear to be highly conserved in vertebrates, and produce the same main
cell types: enterocytes, Goblet cells, and enteroendocrine cells31-33. Cell division in
crypts is dependent upon Wnt/β-catenin signaling, in which the Lgr5+ stem cells
differentiate into progenitor cells. From the progenitor cells, the Notch ligand Delta
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turns on transcription factors such as Hes-1 to specify enterocyte fate31, 34 while the Ascl1
transcription factor plays a role in specification of goblet and enteroendocrine cells35.
Interestingly, a previous study in our lab found that arsenic exposure decreased
Ascl1 expression by ~ 4-fold during embryonic stem cell differentiation in vitro, thereby
reducing the formation of sensory neurons36, 37. Since Ascl1a also plays a crucial role in
intestinal stem cell differentiation, we hypothesize that arsenic may also impact intestinal
development in vivo. Thus, the goal of the current study is to determine the mechanisms
by which arsenic exposure during embryogenesis permanently impairs growth using
killifish (Fundulus heteroclitus) as the animal model. Potential mechanisms that we will
examine include changes in intestinal stem cell differentiation and structure, changes in
feeding behavior, and changes in growth factors needed for skeletal muscle proliferation.

2. Methods
2.1 Killifish collection
Adult killifish (Fundulus heteroclitus) were collected from the National Estuarine
Research Reserve (NERR) site in Georgetown, SC using baited minnow traps, and
housed at Clemson University for the collection of eggs and milt. All fish throughout this
study were kept on a 16:8 light/dark cycle at 26oC in 18ppt salt water (CoraLife). Adult
killifish were fed Ziegler Zebrafish food twice a day and maintained until egg and milt
collection.
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2.2 Exposure of killifish embryos to arsenic
Eggs were stripped from 3-4 females and milt collected from 1-2 males to fertilize
~300 eggs. Fertilized eggs were randomly placed in one of 28 Petri dishes, and the
process of fertilization continued until each Petri dish contained 80 eggs. The fertilized
eggs were continuously exposed to 0, 10, 50, and 200ppb arsenic, as sodium arsenite,
with 7 replicate petri dishes per concentration. Water changes were done every other day,
and embryos monitored for viability and hatching daily. After hatching, the fry were
placed in 10 gallon tanks with arsenite-free 18 ppt salt water within 24hr of hatching, and
fed 5% of their estimated body weight per day. Juveniles were fed brine shrimp until ~4
weeks of age, then were transitioned to pellet food (Zeigler Brothers). Sampling time
points were at 8, 16, and 28 weeks of age.

2.3 Assessing arsenic metabolite formation
Using the process described above, additional eggs were fertilized and juveniles
grown up in clean water for 16 weeks to assess arsenic uptake and metabolism. Fish
were exposed to 0, 5, or 10ppm arsenic as sodium arsenite (n= 6 tanks per exposure level;
each tank had 2-3 killifish) for 5 days in a static renewal system. Fish were fed twice per
day, and water changes were conducted once a day. Fish were euthanized in buffered
MS-222, rinsed in clean water, patted dry, and frozen whole at -80oC. In order to have
enough tissue mass for speciation, fish from 3 tanks were combined per exposure group,
giving n=2 replicates per concentration.

The arsenic species in our adult fish food

(Ziegler Brothers zebrafish pellets) was also determined.
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All processing and arsenic analyses were conducted by Brooks Applied Labs
(Bothell, WA). Fish and food samples were homogenized and digested in nitric acid
(modified EPA Method 3050B), and total recoverable arsenic performed by inductively
coupled plasma triple quadrupole mass spectrometry (ICP-QQQ-MS). Arsenic species
examined include arsenite, arsenate, monomethylarsonic acid (MMAs), dimethylarsinic
acid (DMAs), trimethyl arsine oxide, arsenocholine, and arsenobetaine. Analyses were
conducted by ion chromatography coupled to an inductively coupled plasma collision
reaction cell mass spectrometer (IC-ICP-CRC-MS). Results are presented as the amount
of each arsenical species per whole body kg wet weight.

2.4 Killifish feeding behavior and growth measurements
Sampling time points were at 8, 16, and 28 weeks of age. Two weeks prior to the
sampling points, feeding behavior was assessed by videotaping fish movement on two
separate days. A grid with 5cm rows was placed in the back of each home tank one week
prior to the start of the test. Shielding was used to hide the observer from the fish, and
fish were not fed for 15 hrs prior to the test. On the day of the test, the normal position of
fish within the tank was recorded for 15 seconds using a video camera mounted to a
tripod. To start the test, zebrafish food pellets (Ziegler) were gently placed in the top of
the water column, and response of the fish to the food was videoed for 60 seconds. Using
the recordings, the following parameters were quantified: 1) time for 10% of the fish to
start moving in response to the stimuli and 2) percentage of fish within each tank
responding. The trials were conducted on two separate days, and averaged per tank.

36

At each sampling time point (8, 16, and 28 weeks of age), 5-6 fish per tank were
euthanized in 1g/L buffered MS-222. Fish were patted dry, and weight, body length and
intestinal length measured. Condition factor (weight/ length3) for each fish was
calculated, and averaged per tank. At the 28 week sampling point, when we were able to
visually determine sex, 3 males and 3 females were sampled per tank, tissue was
collected, labeled with sex, and kept separate. Muscle, liver, and anterior intestine were
collected from 3 of the 6 fish per tank. Tissue samples were stored in RNAlater at -80oC.
Additional anterior intestine sections taken from the other 3 fish per tank for histology
were fixed overnight in 10% buffered formalin, dehydrated in graded ethanol, embedded
in paraffin, cut into 7 µm transverse sections, and placed on slides.
2.5 Intestinal morphology
Morphological changes in the intestines of embryonically exposed fish were
examined by hematoxylin and eosin (H&E) staining (n=4 fish per exposure per sampling
time point). Once gender could be visually confirmed at 28 weeks of age, 2 males and 2
females per exposure was collected for histology. Sections were stained with H&E and
imaged using a Leica ICC50 HD light microscope. ImageJ software (National Institute of
Health) was used to determine height and width (mm) of 5 villi per field of view.
2.6 Immunohistochemistry
Paraffin embedded intestinal sections (7µm) were examined for markers of absorptive
enterocytes (gut absorptive cell epitope antibody; Biorbyt, # orb324078), while the
number of proliferating cells were examined by the expression of proliferating cellular
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nuclear antigen (PCNA) (Abcam, #ab29). Sections underwent antigen retrieval in TrisEDTA buffer, pH9, and were then quenched with 3% hydrogen peroxide for 10 minutes.
Blocking was in avidin- biotin (Vector Labs, Burlingame, CA) for 30 minutes and then
10% horse serum (Vector ABC Elite Kit) for 17 minutes. After washes, the appropriate
dilution of primary antibody (PCNA 1:750; absorptive cells 1:400) was added and
incubated overnight at 4oC. Tissues sections were then washed and biotinylated
secondary antibody was added for 30 minutes. Then Vectastain ABC reagent
(Biotinylated horseradish peroxidase + Avidin DH) was applied to the sections.
Antibody labeling was detected with Nova Red, and sections were counter-stained with
hematoxylin if the primary was not nuclear. Using these antibodies, Goblet cells can be
clearly identified based upon morphology. PCNA positive cells were counted per 2
intervillus regions within field of view at 40X and averaged per villus. Absorptive
surface area was quantified by outlining 4 villi per field of view at 10X for absorptive
surface and determining the percentage of stained cells using ImageJ. The colors were
converted to a black and white image so only cytoplasmic staining of the enterocytes
would be determined. Goblet cells were counted from each of the 4 villi and averaged per
villus. All sections were averaged within the group, and statistical significance was
determined by ANOVA followed by Tukey’s.
2.7 qPCR
RNA was extracted from liver, muscle, and intestines using TRIZol (SigmaAldrich, St. Louis, MO). Purity and RNA concentration were determined using a
NanoDrop Lite ,and 2µg RNA was reverse-transcribed to cDNA using MMLV-RT. To
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conduct qPCR, 40ng cDNA, RT2 SYBR Green mix (Qiagen, Alameda, CA), and genespecific primers (Table 1) were run in triplicate on a iQ5 thermocycler (BioRad). For 8
and 16 weeks, 5 fish per exposure group were randomly selected to run on one plate per
gene. At 28 weeks, 5 fish per gender were examined. A 5-point standard curve (10-3 to
10-7 ng) for each gene was used to determine the efficiency and linearity of each reaction.
In muscle, levels of insulin-like growth factor-1 (IGF-1), insulin-like growth factor-1
receptor (IGF-1R), and insulin-like growth factor binding protein 5 (IGFBP-5) were
examined. In the liver, expression of insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein 1 (IGFBP-1) were examined. In the intestine, levels
of the solute carrier SCL15A1b were examined. Samples were run in triplicate and gene
expression data was normalized with 18S rRNA as the housekeeper using the
comparative threshold (Ct) method38. All comparative threshold averages were
compared to the control, which was set at a value of 1.
Primer

Forward

Reverse

ºC

18s

5’-TTT CTC GAT TCT GTG GGT GGT GGT-3’

5’-TAG TTA GCA TGC CGG AGT CTC GTT-3’

60

IGF-1

5’- AAA CAG ATA AAC CAACAG GCT ATG-3’

5’-GCA GCT CAC AAC TCT GGA A-3’

54

IGF-1R

5’-CGT CTT TGA CCA CAC CCT T-3’

5’-CGC AGA AAT GTA CGT ACC AGA-3’

55

IGFBP-5

5’GAA GGA CAC TTC TCG GGT TAT G-3’

5’ TTG CAC TGT TTG CGC TTG-3’

56

IGFBP-1

5’ CAT GGC TCT GTG CAC TAC AT-3’

5’ ATC GCG TTA ACT CTG GCT TT-3’

59

SLC15Alb

5’-CTC CAC AAC CAT CTA CCA CAC-3’

5’-CTC ATG GCT CGG AAA GTT CA-3’

52

Table 1. Killifish qPCR primers
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2.8 Statistical analysis
To analyze differences in arsenic metabolites, condition factor, feeding behavior,
intestinal morphology, SCL15A1b gene expression, number of PCNA+ cells, and the
number of goblet cells, an ANOVA followed by a Tukey’s (JMP) was used to compare
differences between exposure groups. In all cases, a fit model showed there was no
effect of day, tank, or sex. For transcript expression in the liver and skeletal muscle,
multivariate ANOVA was used to test equality of the two variables across the doses. If
MANOVA suggested differences in the four doses, multivariate contrasts were used to
determine significances of the two variable between specific sets of doses. This allowed
us to determine the exact nature of the dose impact of the two variables being analyzed at
a given time point. Data was consider significant if p<0.05.
3. Results

3.1 DMA and MMA make up a high percentage of arsenic species in killifish
First, we wanted to
determine whether killifish
could metabolize arsenic into
mono- and dimethylated
metabolites in a manner similar
to humans. Sixteen-week old
killifish were exposed to 0, 5, or
10ppm arsenite, and levels of As (III), As (V), monomethylarsonic acid (MMA),
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dimethylarsinic acid (DMA), and arsenobetaine (AsB) quantified. AsB was the only
arsenical species present in the control fish, and its levels did not change due to arsenic
exposure (average = 417+62g/kg; data not shown). DMA, MMA, As (III), and As (V)
were below the detection limits in control fish, and their values increased in a doseresponsive manner in the 5ppm and 10ppm exposure groups (Figure 1) with DMA
accounting for 45-61% and MMA accounting for 15-17% of the total arsenicals. These
percentages are similar to paired maternal and newborn blood samples exposed to 90ppb
arsenic in their water, in which 43+9% of total arsenic was as DMA and 31+6% was as
MMA17. Note that in (Figure 1) we are looking at whole body levels, rather than blood
levels, which accounts for some of the variation in MMA and DMA percentages. The
adult fish food contains arsenical species, but >98% of them are arsenobetaine and
arsenocholine, with As (III) levels below the detection limit. Arsenite in our water is also
below detection limits (data not shown). These data indicate that killifish readily
metabolize arsenic, and can be used as models for human exposures.

3.2 Embryonic arsenic exposure reduces condition factors in 8 week old killifish
To assess whether embryonic-only arsenic exposure altered growth in juvenile
and adult killifish, condition factors (CF; weight/length3) were determined. Killifish
were exposed as embryos, and after hatching, were grown out in clean water. No
differences in hatchling success or survival up to 28 weeks of age were seen (data not
shown). At 8 weeks of age, condition factor was significantly reduced at 200ppb by 20%
compared to the control (Figure 2A). No difference was found at 16 or 28 weeks among
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any of the exposure groups, but there was a slight trend in condition factor reduction at
16 weeks (Figure 2A). At 28 weeks, when male and females were combined, there were
no differences in condition factor (Figure 2C), although decreases can be seen in the
females when separated from the males.
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3.3 Embryonic arsenic exposure alters feeding behavior
Since reductions and trends in condition factors were seen after embryonic arsenic
exposure, similar to previous studies39, 40, we wanted to examine potential mechanisms
for the lack of growth. Since one possibility is that the arsenic-exposed embryos were
not actively seeking enough food, we assessed differences in feeding behavior. At 8
weeks of age, the arsenic-exposed fish appear to take longer to respond to food, with the
control fish taking an average of 23 seconds to respond to food placed in their tanks and
the arsenic exposed fish taking an average of 33 seconds, but there were no significant
differences
compared to the
control (Figure 3).
At 16 weeks of age,
there was a
significant 1.7-fold
increase in the
average time to start
a response in the 10
ppb embryonicallyexposed fish (Figure
3). While the 50 and
200ppb exposure groups also had start time increases of 1.4- to 1.6-fold, there were no
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significant differences (Figure 3). At 28 weeks of age, there was a significant 2-fold
increase in the start time for 200 ppb group, and increases of 1.2- to 1.6-fold time to start
for the other groups. Similarly, the percentage of fish responding to food within the first
minute at 28 weeks of age was decreased in the arsenic exposed groups, ranging from a
7% to a 20%t decrease (Figure 3). These data indicate that embryonic arsenic exposure
can inhibit responsiveness to feeding which could therefore be a potential reason for
reductions in growth.

3.4 Embryonic arsenic exposure reduces intestinal villus height
Another possible mechanism for the reductions in growth was that embryonic
arsenic exposure reduced the number of enterocytes or otherwise altered the ability of the
intestine to absorb nutrients. To first examine morphometric changes, hematoxylin and
eosin (H&E) staining was used to quantify average intestinal villus area by multiplying
height and width (Figure 4A). No significant differences were found at 8 weeks of age.
At 16 weeks of age, there is some reduction in villus area, but these differences do not
persist at 28 weeks of age (Figure 4B). The reduction in villus area at 16 weeks does
follow similar trends with reduced SCL15A1b peptide transporter expression (Figure S1.
supplemental data), which was examined since other studies in mice have seen
correlations between reduced SCL15A1b peptide transporter expression, reduced villus
height, and reduced weight gain2
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3.5 Embryonic-only arsenic exposure reduces number of PCNA (+) cells and
absorptive surface
Immunohistochemistry was used to examine the number of proliferating cells
(Figure 5A), enterocytes, and goblet cells (Figure 5B). Since a fit model indicated there
was no significant effect of sex, all data were combined. The data show that embryonic
arsenic exposure
appears to reduce the
number of
proliferating cells up
to 28 weeks after
exposure, but only a
trend was found
(Figure 6). Similarly,
the percentage of cells
labeled as enterocytes,
were reduced,
although this was only
statistically significant
in the 50ppb exposure
group at 28 weeks
(Figure 6B). There were no differences in the numbers of Goblet cells, which averaged
3.5-5 cells per villus (Figure 6C).
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3.6 Embryonic arsenic exposure alters skeletal muscle IGF-1 and IGFBP-5
transcript expression
Since few changes were seen in intestinal cells types or morphology, we wanted
to see if there were changes in genes involved in the IGF-1 pathway as it is a major
promotor of growth, especially during the juvenile stage. In a previous study, we had
seen that embryonic arsenic
exposure at higher

A
.

B
.

concentrations and later time
periods resulted in increased
expression of muscle IGF-1 and
IGF-1R39. We wanted to expand
upon this earlier study by
examining a more
comprehensive set of genes, and
assess whether lower arsenic
concentrations also resulted in
the same effect. Thus, in
addition to examining muscle
IGF-1 mRNA levels, we also
assessed levels of the pro-myogenic
retention protein IGF binding protein

Figure 7. Muscle IGF-1 and IGFBP-5 increase at 8 and 16
weeks then are reduced by 28 weeks. At each time point
muscle IGF-1 and IGFBP-5 were quantified using the
comparative threshold method (2^ddCt). Averages were analyzed
for significant difference (p<0.05) indicated by (*) using the oneway ANOVA method (n=5 per exposure per time point).

-5 (IGFBP-5)41. At 8 and 16 weeks of grow-out in clean water, muscle IGFBP-5 and
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IGF-1 levels increased in the 50 ppb group compared to the control (Figure 7).
Additionally there was a notable increase in IGFBP-5 at 16 weeks in the 10 ppb.
However, by 28 weeks, there is a decrease in IGFBP-5 expression in the 10 ppb group,
along with a trend such that muscle IGF and IGFBP-5 levels are reduced in all exposures
(Figure 7). No real trends were seen at any time points with IGF-R (data not shown).

3.7 Arsenic exposure alters the correlation between hepatic IGF-1 and IGFBP-1
Since the liver is the primary
organ for IGF-1 synthesis, we analyzed
hepatic IGF-1 levels as well as the
IGFBP-1 binding protein, which
sequesters IGF-1 under stress making it
less bioavailable42. When the
relationship between hepatic IGF and
IGFBP-1 was compared, there is a
significant correlation between the two at
the 8 and 28 week time points (r2=0.93
and 0.98, respectively). At 16 weeks, the
correlation is still apparent, but is not
statistically significant (r2=0.80). At 8
weeks, there is a significant reduction in
IGF-1 and its binding protein at all

Figure 8. Liver IGF-1 and IGFBP-1 decrease at 8
weeks and then increase at 16 and 28 weeks. At each
time point liver IGF-1 and IGFBP-1 were quantified using
the comparative threshold method (2^ddCt). Averages
were analyzed for significant difference (p<0.05) indicated
by (*) using the MANOVA and multivariate contrast.
method (n=5 per exposure per time point). (n= 5 per
exposure)
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arsenic exposure groups compared to the control (Figure 8). At 16 and 28 weeks, the
comparisons have changed such that hepatic IGF-1 and IGFBP-1 are significantly
increased at the 200ppb group, and a trend towards increasing expression exists at 10 and
50ppb at both time points (Figure 8). The pattern in decreasing liver IGF-1 correlates
with a decreasing condition factor at 8 weeks of age therefore, indicating embryonic
arsenic exposure could reduce liver IGF-1 in correlation with a reduction in growth
(Figure 9).

*

*

*

*

Figure 9. Liver IGF-1 and condition factor decrease at 8 At each
time point liver IGF-1 quantified using the comparative threshold
method (2^ddCt). Condition factor and IGF-1 liver Averages were
analyzed for significant difference (p<0.05) indicated by (*) using the
MANOVA and multivariate contrast method (n=5 per exposure per
time point).
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4. Discussion
The results of this study indicate that embryonic arsenic exposure reduces growth
of killifish early on during juvenile stages. Reductions in feeding behavior and changes in
IGF signaling pathway transcript levels might be underlying mechanisms as to why
arsenic can reduce growth long after the exposure has ended.

4.1 Embryonic arsenic exposure reduces growth at early time points
A previous study examining embryonic-only arsenic exposure and long term
growth found that at 16 and 28 weeks, condition factor was reduced in the arsenicexposed groups (50 , 200, and 800ppb) and the reduction persisted up to 52 weeks39.
Additionally, a study looking at earlier time points, but at much higher exposure
concentrations, found that 800-5000ppb embryonic arsenic exposure reduced weight in 8
and 16 week old juvenile fish40. The current study was conducted to assess the
mechanisms responsible for these changes in growth at more environmentally relevant
embryonic arsenic exposures. After analyzing condition factor at 8 weeks, there were
dose-dependent reductions in all exposure groups, but a significant reduction (24%) was
only found in the 200 ppb embryonic exposure group. At 16 weeks, there is a dosedependent trend for reduced condition factor. These findings were expected and indicate
that embryonic exposure to arsenic can reduce growth and weight gain during the
juvenile period. However, by 28 weeks, the females show a reduction in condition factor
in a dose-dependent manner, but the males actually had an increase in condition factor in
the exposure groups.
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These findings are not entirely consistent with our previous study. However,
when the food from the previous study was analyzed for specific arsenic species, we
found it contained small amounts of trivalent arsenic such that a fish at 16 weeks of age
weighing an average of 0.3g would have received a continuous arsenic exposure
equivalent to 2.25ppb arsenic, while a 28 week old fish weighing ~1g would have
received an exposure equivalent to 7.5ppb continuously. The zebrafish food used in our
current study had trivalent arsenic levels below the detection limit. Thus, the earlier
study may have had more pronounced growth reductions because of continuous exposure
to arsenite through the diet.
In addition, studies have shown that gender differences can impact the toxicity of
arsenic43, 44. A recent study looked at gene expression differences in males and females
in utero exposed to 0.36 µg/L arsenic on average through household tap water.
Aquaporin 9 (AQP9), a known transporter of trivalent arsenic, was positively correlated
with maternal urinary arsenic (U-As) levels in female offspring, but not in male
offspring45. Additionally, this study examined expression of developmental genes
involved in the Wnt, Notch, and stem cell regulator pathways and found that genes such
as LGR5, HES1, GLI3 were negatively associated and IGFBP6 was positively associated
with AQP9 levels in females. This study suggests that AQP9 transport of inorganic
arsenic could be a mediator of arsenic’s sex-specific birth weight reductions in females,
and the investigators hypothesized that estrogen might play a role in facilitating
transcription of AQP9 in liver cells 45. Another study found a reduction in birth weight in
females by 1.5 g per 1µg/L increase in urinary arsenic concentrations, but only a

52

reduction of 0.15 g birth weight in males. Only female birth weight was positively
associated with GLI3 and LGR5 and negatively associated with urinary arsenic levels46.
These finding indicate that exposure to arsenic during early developmental time points
can have sex- specific outcomes that relate to reductions in birth weight. The reduction in
condition factor in females in our study is similar to an epidemiology study that looked at
children exposed in utero to arsenic, and found that 5 years later, there was a significant
reduction in weight gain and height with 41% of the children being underweight and 33%
were stunted, and that these effects were most apparent in girls47. Therefore, arsenic
might inhibit proper growth in females more than it does in males.
As growth was reduced at early time points in embryonic-arsenic exposed
killifish, it was interesting to observe the reduced feeding behavior. In our study, we
noticed an increase in time to feed and a decrease in the number of fish actively feeding,
particularly at 16 and 28 weeks of age. An increase in the time it takes to start feeding
could potentially indicate a lack of interest in feeding, decreased olfactory ability to
detect the food, or hypoactivity. Previous studies have shown that embryonic arsenic
exposure reduced feeding behavior in killifish at 28 and 40 weeks of age following an
embryonic exposure of 200 and 800 ppb asrenic39, which is in line with our findings.
Similarly, a study in rainbow trout found that exposure to cadmium and copper reduced
the ability of the fish to detect L-alanine, an amino acid that mimics food48, while
exposure to copper induced apoptosis in salmon olfactory sensory neurons, thereby
inhibiting behaviors critical to salmon survival such as food detection49. Indeed, a
number of investigations have determined that the olfactory epithelium is a target of
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metal toxicity. Additionally, a study found that zebrafish embryos exposed to arsenic
exhibit hypoactivity during embryonic tail flexions from a photomotor response25. While
we did not quantify normal activity in the embryonically-exposed killifish, we
hypothesize that arsenic exposure either alters their ability to detect food or reduces their
normal swimming activity. These changes in behavior as a result of exposure to
toxicants can affect the fish’s capacity to feed25, 50, and therefore reduce growth.
In addition to feeding behavior changes, intestinal morphology and numbers of
specific cell types might play a role in the ability to uptake nutrients. Indeed, we found a
reduction in intestinal area in all exposure groups at 16 weeks of age. Intestinal villus
height was a part of the area calculation and height plays an important role in increasing
absorptive surface area, which could help increase growth51. Furthermore, proliferating
cells are essential in the intestine as the cell turnover is typically 5-7 days, at least in
zebrafish32. In this study, we found a decreasing trend in the number of PCNA cells in a
dose dependent manner at 8, 16, and 28 weeks. A decreasing trend in PCNA could
indicate a decreased ability for intestinal cellular proliferation, which is needed to
maintain the different cell types in the intestine.
One type of cell is the enterocyte, which make up ~80% of the intestinal epithelial
cells, and have absorptive functions to take up nutrients53. In our study, we found a
significant decrease in absorptive surface which is primarily made up of enterocytes, at
16 weeks of age, but not any other time points. This could be associated with the
reduction in villus area at 16 weeks as well as a reduction in PCNA cells. If the number
of cells is decreased from 8-16 weeks, this could indicate that intestinal cells are not
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proliferating at a sufficient rate, therefore decreasing the size of the villus and
subsequently the absorptive surface area of enterocytes. Arsenic has been found to cause
oxidative damage leading to necrosis in intestinal epithelial tissue in rats exposed to 600
ppb in the drinking water54. Overall, the trend in decrease villus height and decrease in
absorptive surface at 8 and 16 weeks could be a mechanism involved in reducing
condition factor.

4.3 Arsenic exposure alters insulin-like growth factor (IGF) pathway transcript
levels
IGF-1 is an important signaling pathway involved in growth of mammals as well
as fish that can act in an autocrine, paracrine, and endocrine manner56, 57. IGF-1 mRNA
expression is modulated by nutrition in a number of fish, and there are strong arguments
for IGF-1 as a biomarker of growth in fish58. In several fish studies, IGF-1 mRNA
expression is directly related to plasma IGF-1 levels59. Production of IGF-1 protein is
stimulated by growth hormone (GH) produced by the anterior pituitary gland, which then
binds to its receptor in the liver to signal hepatic cells to synthesize IGF-1 through the
JAK/STAT pathway59,60. Then IGF-1 is distributed to tissue types with IGF-1 receptors
(IGF-1R) that activate the PI3K-AKT-TOR signaling pathway in the target tissue to
increase the expression of genes such as myogenic regulator factors, PCNA, and
myostatin61. Additionally, in vitro or in vivo treatment of tilapia with estradiol decreased
IGF-1mRNA in the liver, which could help explain why there might be sex differences in
growth in the presence of steroid hormones62. IGF-1 is bound by binding proteins
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(IGFBP) that either transport IGF-1 to its receptors on target tissue, or bind and sequester
IGF-1 under stressful conditions such as malnutrition41, 42, 63. The interesting correlation
in this study is that at 8 weeks, when there is a dose-dependent decrease in condition
factor, there is also a significant decrease in liver IGF-1. Another study found that prepubertal mice exposed to arsenic had reduced circulating levels of IGF-1 64. While
hepatic IGF-1 levels follow growth patterns at 8 weeks, when we analyzed 16 and 28
weeks, there was a shift in the hepatic IGF-1 and IGFBP-1 levels where it was
upregulated in a dose dependent manner, potentially as a compensatory mechanism to
catch up in normal growth.
Our previous study examining embryonically-exposed killifish at 52 weeks of age
noticed an increase in muscle IGF-1 levels39. We hypothesized that arsenic had reduced
liver IGF-1 levels and the fish were compensating by producing more IGF-1 in the
skeletal muscle. While the liver is the primary organ of IGF-1 synthesis, other tissues,
such as skeletal muscle, can produce IGF-1 if under stress or ablation of the primary
hepatic source of IGF-165. For muscle IGFBP-5, the promyogenic binding protein in
muscle that increases IGF bioavailability by greatly increasing IGF-1 half life41, 66, there
were increases in its transcript levels at 8 weeks in the fish embryonically exposed to
arsenic. While growth was reduced at 8 week and liver IGF-1 levels were decreased, the
killifish could have been increasing IGFBP-5 as a compensatory growth mechanism. By
28 weeks of age, we noticed a complete shift in that all exposure groups had reduced
muscle IGF-1 and IGFBP-5 levels and increased liver IGF-1 and IGFBP-1 levels.
Therefore, this supports the idea that when the main organ of IGF production, the liver, is
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not synthesizing or producing IGF in adequate amounts, the other tissue trying to grow
such as muscle will produce it in order to compensate for growth deficits67. Studies have
shown that in utero arsenic exposure can decrease birth weight which correlates to
reduced IGF levels20. While we see reduction in growth and hepatic IGF-1 levels early
on, it appears that embryonic arsenic effects are remediated potentially by compensating
through increasing local production of muscle IGF until normal hepatic IGF levels are
restored.

5. Conclusion
Embryonic only arsenic exposure can produce reductions in growth during
juvenile life stages. Reductions in growth might be due to alterations in feeding
behavior, reductions in intestinal villus height and absorptive surface, and alterations in
IGF-1, IGFBP-1, and IGFBP-5 in liver and skeletal muscle at early time points. This
could indicate that while arsenic can impair growth early on, the fish may be able to
overcome its effects at these lower levels of arsenic exposure by increasing the
production of IGF-1 and IGFBP-5 in skeletal muscle as a growth compensatory
mechanism.
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CHAPTER THREE

CONCLUSION
While there is a good amount of literature on arsenic’s effects on growth, there is
still a need for research on arsenic’s effects during the embryonic and fetal period, along
with its long term consequences. It is already known that arsenic exposure in utero via
mother’s ingestion of contaminated water is correlated with reductions in IGF-1 plasma
levels and weight gain even 4.5 years after exposure 1, 2. Reductions in plasma IGF-1
have even been found in other animal models where female rats were exposed to 10
mg/kg AsIII, which resulted in an average daily intake of 575µg/day per female rat which
be the equivalent to human daily intake of 57.5 µg based on a 10 fold difference due to
differences in metabolism of arsenic between humans and rodents 3. This study found
that arsenic exposure suppressed circulating levels of IGF-1 and authors hypothesized
that arsenic exposure reduced hepatocyte viability3. As IGF-1 regulates growth during
fetal and postnatal periods, if the liver is damaged through oxidative stress, the secretion
of hepatic IGF-1 might be impaired3. Studies have shown that arsenic exposure increased
levels of MDA in hepatic tissue in brown trout indicating lipid peroxidation from
oxidative damage4.
Since arsenic is found all over the world in groundwater at levels that exceed the
WHO safe drinking water standard of 10 ppb8,9 and can easily cross the placental
barrier10 exposure to arsenic is of great concern11-14. A previous study found that arsenic
levels in the maternal blood (11.7μg/L) and cord blood (15.7μg/L total arsenic) were
similar when pregnant mothers were exposed to drinking water containing 90.5μg As/L,
which indicates that the fetus might be readily exposed to arsenic levels that could
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interfere with growth and development15. Similar metabolism and methylation pathways
of arsenic occur in aquatic animals and mammals, but fish tend to accumulate higher
levels of arsenobetanine and arsenocholine5. Our body burden study removed
arsenobetanine, which is non-toxic16, and found that when 16 week-old killifish were
exposed to 5 and 10 ppm arsenic, they accumulate 1429 and 2832 μg/kg respectively.
Using linear regression, exposures of 10, 50, and 200ppb would result in body burdens
ranging from 48 – 101.8 μg/kg. While these levels are of whole body accumulation
instead of plasma or urine, it still indicates a fairly high body burden. Typically, a 10fold safety factor is used in risk assessment when extrapolating from a surrogate species
to humans, and another 10-fold safety factor added to account for variability in a
population. So, if adverse effects are seen at a 10ppb exposure, and safety factor of 100fold is included, the body burden levels which are considered to be protective are in the
range of 0.4g/kg. Using the maternal-fetal study above, an exposure of 90μg As/L
results in 12 μg/L arsenic in the blood, or that approximately 13% of the ingested arsenic
is accumulated. Then you can assume if an adult consumes about 3L of 10ppb arsenic
contaminated water a day, this might yield levels of 4 -5μg/L per kg in both the mother
and fetus. Studies have estimated that arsenic exposure between 0.3 and 8 µg/kg body
weight/day results in a 1% increased risk of lung, skin, and bladder tumors in humans17.
Additionally, the U.S. Agency for Toxic Substances and Disease Registry’s (ATSDR)
Minimal Risk Levels (MRLs) for acute oral consumption at 5µg/kg/day and chronic oral
consumption at 0.3µg /kg/day arsenic as safe doses for infants18. However, our data
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suggests that these values might not really be protective enough and that drinking water
standards for arsenic may need to be lowered.
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APPENDIX A

Supplementary Figure 1. Arsenics increases SCL15A1b at 8 weeks, a peptide transporter in the
intestine, after 10ppb embryonic exposure.

Figure S1. Average SCL15A1b 2^ddCt is compared at 8, 16, and
28 weeks. 8 week time point show significant increase in the 10 ppb
when on-way ANOVA was run * p<0.05 compared to control. (n=5
per exposure for each time point)
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